We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DM
126
DELISTED
Dominion Energy Midstream Ptr LP
DM
| $4.06M | 0.08% |
151,115
-7,665
| -5% | -$258K |
|
127
AT&T
T
$174B
| $3.94M | 0.08% |
159,905
+32,474
| +25% | +$828K |
|
128
Criteo S.A.
CRTO
$845M
| $3.85M | 0.08% |
102,454
+14,033
| +16% | +$642K |
|
129
AerCap
AER
$23.3B
| $3.85M | 0.08% |
100,560
-4,920
| -5% | -$217K |
|
130
lululemon athletica
LULU
$13.1B
| $3.81M | 0.08% |
75,285
-11,470
| -13% | -$699K |
|
|
LUX
131
DELISTED
Luxottica Group
LUX
| $3.72M | 0.08% |
53,700
-47,079
| -47% | -$3.26M |
|
132
Canadian National Railway
CNI
$76.5B
| $3.67M | 0.07% |
64,720
+31,365
| +94% | +$1.83M |
|
133
IBM
IBM
$225B
| $3.6M | 0.07% |
25,995
-405
| -2% | -$59.8K |
|
134
Wells Fargo
WFC
$257B
| $3.56M | 0.07% |
69,364
+4,982
| +8% | +$274K |
|
135
Abbott
ABT
$193B
| $3.56M | 0.07% |
88,418
-3,725
| -4% | -$176K |
|
|
BWLD
136
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $3.53M | 0.07% |
18,270
+12,996
| +246% | +$2.44M |
|
137
Bright Horizons
BFAM
$3.62B
| $3.5M | 0.07% |
54,560
+35,977
| +194% | +$2.22M |
|
138
Qualcomm
QCOM
$176B
| $3.5M | 0.07% |
65,094
-18,397
| -22% | -$1.09M |
|
139
Equinor
EQNR
$98.6B
| $3.42M | 0.07% |
234,864
-9,804
| -4% | -$155K |
|
|
ESRX
140
DELISTED
Express Scripts Holding Company
ESRX
| $3.37M | 0.07% |
41,588
+7,540
| +22% | +$657K |
|
141
RTX Corp
RTX
$286B
| $3.31M | 0.07% |
59,057
-2,839
| -5% | -$175K |
|
142
Philip Morris
PM
$297B
| $3.29M | 0.07% |
41,515
+2,964
| +8% | +$244K |
|
|
LDRH
143
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $3.26M | 0.07% |
94,453
+55,764
| +144% | +$2.27M |
|
|
NVO
144
Novo Nordisk
NVO
$205B
| $3.26M | 0.07% |
120,102
-6,268
| -5% | -$177K |
|
|
IMPV
145
DELISTED
Imperva, Inc.
IMPV
| $3.26M | 0.07% |
49,748
+22,630
| +83% | +$1.5M |
|
146
3M
MMM
$92.2B
| $3.2M | 0.06% |
26,973
-200
| -0.7% | -$24.6K |
|
147
Accenture
ACN
$115B
| $3.11M | 0.06% |
31,612
-338
| -1% | -$33.5K |
|
148
Aemetis
AMTX
$135M
| $3.1M | 0.06% |
1,128,730
+201,625
| +22% | +$657K |
|
149
T. Rowe Price
TROW
$24B
| $3.09M | 0.06% |
44,446
+1,809
| +4% | +$134K |
|
150
ASML
ASML
$666B
| $3.07M | 0.06% |
34,931
-9,589
| -22% | -$908K |
|
Similar funds
CAM
VKH
DL
RBC
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.